 The
iShares MSCI Israel ETF (EIS) is an exchange-traded fund that tracks
the investment results of an index composed of Israeli equities. EIS
seeks to track the MSCI Israel IMI 25/50 Index, which includes
companies of all sizes in the Israeli equity market.
As of
September 2021, the top holdings of EIS include Teva Pharmaceutical
Industries, Check Point Software Technologies, Bank Hapoalim, and Bank
Leumi Le-Israel BM. The fund has a significant allocation to the
technology sector, with over 40% of its holdings in this industry.
EIS provides investors with exposure to the Israeli equity market,
which is home to several innovative and rapidly growing technology
companies. However, the fund's concentrated exposure to the technology
sector could increase its volatility and risk.
Investors
looking to gain exposure to the Israeli equity market through EIS
should consider the potential risks and conduct thorough research on
the fund and its underlying holdings before investing. Additionally,
investors should consider the potential impact of geopolitical risks
on the Israeli equity market.
|
